Cancer
Conditions
Brief summary
To learn more about participant experience as a Asian American immigrant breast cancer survivor and how writing about participant experiences may affect participant's health.
Detailed description
Primary Objective: To determine the effects of writing therapy on QOL and perceived stress at the 6- and 12-month follow-ups. Secondary Objective: To discover the effects of writing therapy on stress biomarkers and perceived stress at the 3-month follow-up. To explore the psychosocial and cultural mechanisms responsible for the benefits of writing therapy by using mixed methods.
Interventions
BEHAVIORALEsays
Participants will write about their experiences One (1) time each week for 3 weeks at the beginning of the study and then 1 more time 9 months later. Participants will be asked to write about their experiences with cancer in English or Chinese and to write as much as they can for about 20-30 minutes for each essay.
BEHAVIORALQuestionnaires
Participants will answer a questionnaire at the beginning of the study and then 3, 6, and 12 months later. Participants will also answer a questionnaire about their thoughts on writing and on the study after they complete the third essay.
Sponsors
M.D. Anderson Cancer Center
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult (aged 18 and older) diagnosed with stage 0-III cancer (or acute leukemia in remission/ chronic myeloid leukemia in chronic phase). * Self-identified as Asian, Asian Americans, any Asian or Asian American subgroup (Chinese, Vietnamese, Indian, Korean, etc.) ethnic/cultural background * Completed primary treatment, including surgery, chemotherapy, and/or radiation therapy, immunotherapy, or targeted therapy within the preceding 5 years. * Comfortable reading in English or in Chinese.
Exclusion criteria
\- Inability to provide informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcome Measure: Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 | Time Frame: through study completion; an average of 1 year |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORQian Lu, MD, PHD
M.D. Anderson Cancer Center
Outcome results
None listed